about
Reliable and effective oxygen-ozone therapy at a crossroads with ozonated saline infusion and ozone rectal insufflation.Selective ozone concentrations may reduce the ischemic damage after a stroke.The usefulness of ozone treatment in spinal painThe ozone paradox: ozone is a strong oxidant as well as a medical drug.Oxygen/ozone as a medical gas mixture. A critical evaluation of the various methods clarifies positive and negative aspects.May oxygen-ozone therapy improves cardiovascular disorders?Topical applications of ozone and ozonated oils as anti-infective agents: an insight into the patent claims.Malaria chemotherapy: recent advances in drug development.Emerging topics in cutaneous wound repair.A rational approach for improving the ascorbate antineoplastic activity.New alpha-(N)-heterocyclichydrazones: evaluation of anticancer, anti-HIV and antimicrobial activity.What is the best strategy for enhancing the effects of topically applied ozonated oils in cutaneous infections?Ozone acting on human blood yields a hormetic dose-response relationship.An integrated medical treatment for type-2 diabetes.Important details to be clarified about the effect of rectal ozone on the portal vein oxygenation.Effects of ozone blood treatment on the metabolite profile of human blood.Solubility, spectroscopic properties and photostability of Rhein/cyclodextrin inclusion complex.Ozonated oils as functional dermatological matrices: effects on the wound healing process using SKH1 mice.How much ozone bactericidal activity is compromised by plasma components?A realistic evaluation of the action of ozone on whole human blood.Oxygenation-ozonation of blood during extracorporeal circulation: in vitro efficiency of a new gas exchange device.A precise knowledge of ozonated oils will help to define the favourable and peculiar properties of these functional dermatological matricesOzonated sesame oil enhances cutaneous wound healing in SKH1 miceAre Dialysis Devices Usable as Ozone Gas Exchangers?Properties of sesame oil by detailed 1H and 13C NMR assignments before and after ozonation and their correlation with iodine value, peroxide value, and viscosity measurementsThe irrationality of a non-specific immunomodulation therapy used in cardiovascular diseases deserves a critical commentRandomised, double-blinded, placebo-controlled, clinical trial of ozone therapy as treatment of sudden sensorineural hearing lossThe failure of HIV vaccines: A new autovaccine may overcome some problemsPhysico-Chemical Characterization of Sesame Oil DerivativesA physicochemical investigation on the effects of ozone on bloodHow an ill-conceived methodological approach can condemn the medical use of ozone therapyEffects of surfactants on the spectral behaviour of calcein (II): a method of evaluationPhysicochemical and biopharmaceutical characterization of endo-2-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2,3-dihydro-1H-benz[e]isoindol-1-one (CR3124) a novel potent 5-HT3 receptor antagonistSpectroscopic characterization of both aqueous and solid-state diacerhein/hydroxypropyl-β-cyclodextrin inclusion complexes
P50
Q34031139-29BEC9BE-C571-4BBA-B7E7-9AB0A8F8058FQ34635254-6AC60805-1F19-4897-9913-AFF67AC90A8BQ34670106-8C3E4D42-BE1D-4608-8E82-76D7DE48F89CQ34956322-B708077A-8CF9-4DC2-9C53-CD8DCCC0100FQ35595640-C8861574-F231-4C61-8ED2-A9D708F02E05Q37515676-395832E8-4228-4B55-AE85-8B426908CEFDQ37516252-535328A4-8287-4550-9B33-F1502CAAA01CQ37782360-FC444946-47F6-4307-B3BB-B97AD07F73E3Q38023571-743D5A7D-9E44-4396-B8AE-C0E2FF7F4FD5Q38185439-C7DD8F5E-65FE-4A55-B6F2-1C72D1B3DD8AQ40585209-97827B8D-4349-45B7-8FDD-DDDE2064483EQ41786355-12D222EC-D039-4A4F-A10F-6D77E2808752Q42116788-029C703E-0E49-4C85-9BF3-0C6061940E5FQ42222554-B706C9F1-4429-4C37-B8E4-EB30B55C0AB5Q42876799-67E65A36-9ECD-4DF4-88DA-29E2E4B8046BQ43119644-9C9853C5-1E95-43D6-A72A-1A10FADCB1DBQ43254602-630A638D-127A-4829-9FA9-DCF0A236CC47Q44793636-C7A5DD2E-E307-4FAA-9FE2-1AFCD52C414AQ46117653-BC5AACB9-29B3-4E49-A175-3A4C00315304Q47596102-1333D746-5242-4707-A750-2F69B0E69AC0Q50925283-E2CC38DF-F111-469D-9799-0F24995AAA26Q59189392-8596F129-5338-4480-AD9E-738E3EFE6F94Q59189414-9D76FD96-5C67-4424-8DFD-A981967164D7Q59189422-9EDE6455-AF1F-4729-A804-56A3A375D8A1Q59189429-679C7861-952F-45ED-A5B1-0A43A7140159Q59189436-17C58616-B2E2-4EE1-A80E-619101DA56DEQ59189450-70A6FE46-F406-43D3-8C84-BD269C5B6A86Q59189454-71C50BA4-B4C7-4EC1-951B-2E4593FBB0E5Q59189465-46DB7308-85F1-4432-92BD-E766310C8370Q59189473-4AD00A62-9FCC-4BF7-BB03-B3691350D909Q59189504-5F0F78A3-941C-4E7A-B773-71E74EE1D1F7Q73514147-BF2ADA71-96C8-4C05-946F-B0AC870C9E62Q80150060-AFB7F9A8-DDBE-4CE8-86D0-59137335E359Q87448762-148870DC-466F-40AC-AB64-2BA2410BCE8D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Valter Travagli
@ast
Valter Travagli
@en
Valter Travagli
@es
Valter Travagli
@nl
Valter Travagli
@sl
type
label
Valter Travagli
@ast
Valter Travagli
@en
Valter Travagli
@es
Valter Travagli
@nl
Valter Travagli
@sl
prefLabel
Valter Travagli
@ast
Valter Travagli
@en
Valter Travagli
@es
Valter Travagli
@nl
Valter Travagli
@sl
P106
P1153
6603451420
P21
P31
P496
0000-0002-7574-4456